Wearable Health Solutions, Inc. (WHSI)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Wearable Health Solutions, Inc. (WHSI) trades at $0.00 with AI Score 45/100 (Grade C). Wearable Health Solutions, Inc. (WHSI) specializes in personal emergency response systems and wearable health devices for the elderly and individuals with medical needs. Market cap: $182,671, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for WHSI: WHSI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates WHSI against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
WHSI: the 1 perspectives are evenly split.
How is this calculated? →Wearable Health Solutions, Inc. (WHSI) Healthcare & Pipeline Overview
Wearable Health Solutions, Inc. (WHSI) specializes in personal emergency response systems (PERS) and wearable health devices, serving the elderly and individuals with medical needs. The company develops products like MediPendant and iHelp, focusing on rapid emergency assistance and remote monitoring, positioning itself in the growing telehealth and aging-in-place markets.
What Is the Investment Thesis for WHSI?
Wearable Health Solutions, Inc. (WHSI) is positioned within the growing telehealth and remote patient monitoring sector, focusing on personal emergency response systems (PERS) for an aging population. The company's value proposition is centered on its specialized devices like the MediPendant, offering two-way communication, and the iHelp mobile alert system with remote tracking. A significant growth catalyst is the ongoing development of iHelp+3G, a wearable biosensor device designed for health and wellness monitoring on a 3G network, which could expand its market reach beyond emergency response into preventative care. The increasing global demand for remote patient monitoring, driven by demographic shifts towards an older population and the desire for independent living, provides a fundamental tailwind for WHSI's offerings. However, the investment thesis must acknowledge significant operational and financial risks. The company's market capitalization is currently $0.00B, coupled with a negative profit margin of -320.6%, indicating substantial financial challenges. Its listing on the OTC Other tier suggests limited transparency and liquidity. Future growth is contingent on the successful commercialization of iHelp+3G, securing adequate funding, and achieving sustainable revenue growth in a highly competitive market. Investors should evaluate WHSI's ability to overcome these financial hurdles and effectively scale its specialized product offerings.
Based on FMP financials and quantitative analysis
WHSI Key Highlights
- Market Capitalization: $0.00B, reflecting a micro-cap status.
- Profit Margin: -320.6%, indicating significant unprofitability.
- Gross Margin: 35.9%, suggesting some efficiency in product cost relative to revenue.
- Beta: -0.01, implying very low correlation with broader market movements.
- Focus on Personal Emergency Response Systems (PERS) for the aging population, with active development of the iHelp+3G biosensor device.
Who Are WHSI's Competitors?
WHSI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NYXH Nyxoah S.A. | $1.75 | +1.74% | $69.31M | 69 |
| KMTS Kestra Medical Technologies, Ltd. | $27.70 | +2.67% | $1.62B | 67 |
| ZTEK Zentek Ltd. | $0.46 | +2.88% | $49.90M | 63 |
| OMIC Singular Genomics Systems, Inc. | $20.01 | +0.00% | $50.77M | 61 |
| BLMHF Bloom Health Partners Inc. | $0.11 | +0.00% | $5.22M | 51 |
| FSPKF Fisher & Paykel Healthcare Corporation Limited | $22.52 | +0.00% | $13.23B | 51 |
| CZMWY Carl Zeiss Meditec AG | $32.76 | +3.56% | $2.87B | 51 |
| STAA STAAR Surgical Company | $27.45 | -1.21% | $1.37B | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WHSI's Key Strengths?
- Specialized product portfolio addressing critical needs (MediPendant, iHelp).
- Focus on a growing demographic (elderly, disabled) with increasing demand for PERS.
- Existing international presence in key markets like Denmark and China.
- Active development of next-generation biosensor technology (iHelp+3G).
What Are WHSI's Weaknesses?
- Very low market capitalization ($0.00B) and significant unprofitability (Profit Margin: -320.6%).
- Small operational scale with only 5 employees, limiting capacity for growth and innovation.
- Reliance on older 2G network for current iHelp system, facing potential obsolescence.
- Limited public disclosure and liquidity due to OTC Other listing.
What Could Drive WHSI Stock Higher?
- Successful launch and commercialization of the iHelp+3G wearable biosensor device, expanding product offerings.
- Expansion of the international distribution network in existing or new markets to increase global reach.
- Increasing adoption rates of personal emergency response systems driven by an aging global population.
- Securing strategic partnerships or additional funding to support product development and market expansion initiatives.
What Are the Key Risks for WHSI?
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Significant financial instability, evidenced by a 183K market cap and -320.6% profit margin.
- Intense competition from larger, better-funded companies in the telehealth and medical device sectors.
- Technological obsolescence of current iHelp system due to reliance on the 2G network.
- Challenges in securing sufficient capital for research, development, and scaling operations.
- Limited transparency and liquidity associated with its OTC Other market listing.
What Are the Growth Opportunities for WHSI?
- Development and Commercialization of iHelp+3G: The ongoing development of iHelp+3G, a cutting-edge wearable biosensor device for health and wellness monitoring, represents a significant growth avenue. This product aims to expand WHSI's offerings beyond traditional emergency response into proactive health management, tapping into the broader remote patient monitoring market, which is projected to reach tens of billions globally by the late 2020s. By operating on a 3G network, iHelp+3G promises enhanced connectivity and data capabilities, potentially attracting a wider user base seeking integrated health solutions and providing a more robust platform for future innovation.
- Expanding Reach within the Aging Population Demographic: The global population aged 65 and over is rapidly increasing, creating a sustained and growing demand for personal emergency response systems (PERS). WHSI's core focus on the elderly, individuals with physical disabilities, and those living alone positions it to capitalize on this demographic shift. As healthcare systems increasingly emphasize aging-in-place initiatives, the market for devices that ensure safety and provide immediate assistance will continue to expand, offering a long-term growth trajectory for WHSI's established products like MediPendant and iHelp.
- Penetration of the Telehealth and Remote Patient Monitoring Market: The broader telehealth and remote patient monitoring (RPM) market is experiencing accelerated adoption, driven by technological advancements and shifts in healthcare delivery models. WHSI's current and developing products align directly with this trend, offering solutions that facilitate remote care and monitoring. As healthcare providers and insurers increasingly integrate RPM into standard care protocols, WHSI has the opportunity to expand its partnerships and distribution channels, moving beyond direct-to-consumer and wholesaler models to potentially collaborate with healthcare organizations, thereby accessing a larger institutional market.
- International Market Expansion: WHSI has already established an international presence in Denmark, Ireland, Bermuda, and the People's Republic of China. This existing footprint provides a foundation for further global expansion. Many international markets are experiencing similar demographic trends to the United States regarding an aging population and increasing demand for remote care solutions. Leveraging existing distribution channels and adapting products for specific regional needs could unlock substantial new revenue streams, particularly in regions with high growth potential for medical alert and wearable health technologies.
- Strengthening and Expanding Wholesaler Network: WHSI currently markets its offerings through dedicated websites and wholesalers. Enhancing and expanding its wholesaler network represents a tangible growth opportunity. A robust network of distributors can significantly increase market penetration and sales volume without requiring substantial direct sales infrastructure investment from WHSI. By offering competitive terms, comprehensive support, and innovative products, WHSI can attract more wholesalers, thereby reaching a broader customer base more efficiently across its target geographies, both domestically and internationally.
What Opportunities Does WHSI Have?
- Exploiting the rapidly expanding telehealth and remote patient monitoring market.
- Commercialization of iHelp+3G to capture advanced health and wellness monitoring segments.
- Further expanding international distribution and market penetration.
- Capitalizing on the global trend of aging populations and demand for independent living solutions.
What Threats Does WHSI Face?
- Intense competition from larger, well-funded companies in the medical device and telehealth sectors.
- Challenges in securing adequate funding for product development and market expansion.
- Rapid technological advancements requiring continuous R&D investment to remain competitive.
- Regulatory hurdles and compliance requirements in the medical device industry across various geographies.
What Are WHSI's Competitive Advantages?
- Specialized product features, such as MediPendant's in-pendant two-way speaker for direct communication during emergencies.
- Dedicated dealer portal for iHelp, which streamlines customer base management for its wholesaler network.
- Focused expertise in the personal emergency response systems (PERS) market, catering to a specific demographic.
- Existing international presence in several countries, providing a foundation for global market penetration.
What Does WHSI Do?
Wearable Health Solutions, Inc. (WHSI) operates within the healthcare sector, specifically focusing on medical instruments and supplies, with a core specialization in personal emergency response systems (PERS) and related wearable devices. Established in 2008 as Medical Alarm Concepts Holdings, Inc., the company underwent a significant rebranding in June 2016 to its current name, reflecting its evolving focus on wearable technology solutions. Headquartered in Las Vegas, Nevada, WHSI primarily serves individuals in the United States who face medical challenges or have age-related needs, providing crucial tools for summoning assistance during emergencies. The company's product portfolio is designed to enhance safety and provide peace of mind for its users. A flagship offering is the MediPendant, an emergency alarm system that distinguishes itself with an integrated in-pendant speaker. This feature allows users to engage in two-way verbal communication directly through the device during an urgent situation, ensuring clear and immediate interaction with emergency responders. Complementing this is iHelp, a mobile medical alert system. iHelp leverages T-Mobile's 2G network to provide remote location tracking capabilities, incorporates helpful voice prompts for user guidance, and includes a dedicated dealer portal. This portal facilitates efficient management of the customer base, streamlining operations for wholesalers and distributors. Looking ahead, WHSI is actively engaged in the development of iHelp+3G, an advanced wearable biosensor device. This upcoming product is engineered for comprehensive health and wellness monitoring and is designed to operate on a more robust 3G network, indicating a strategic move towards more sophisticated data collection and connectivity. The target demographic for WHSI's solutions predominantly includes the elderly, individuals with physical disabilities, and those who live independently. WHSI employs a multi-channel marketing strategy, reaching its customer base through its dedicated online platforms, medipendant.com and ihelpalarm.com, as well as through a network of wholesalers. While its primary market is the United States, the company has also extended its international footprint, with operations and distribution reaching Denmark, Ireland, Bermuda, and the People's Republic of China, demonstrating a broader ambition for global market penetration in the rapidly expanding remote patient monitoring and telehealth sectors.
What Products and Services Does WHSI Offer?
- Manufacture personal emergency response systems (PERS) for medical emergencies.
- Develop wearable health devices for health and wellness monitoring.
- Offer MediPendant, an emergency alarm with an in-pendant two-way speaker.
- Provide iHelp, a mobile medical alert system with 2G network tracking and voice prompts.
- Developing iHelp+3G, an advanced wearable biosensor device for 3G networks.
- Cater to the elderly, individuals with physical disabilities, and those living alone.
- Market products through dedicated websites (medipendant.com, ihelpalarm.com) and a network of wholesalers.
- Operate in the United States, Denmark, Ireland, Bermuda, and the People's Republic of China.
How Does WHSI Make Money?
- Sells personal emergency response devices directly to consumers via dedicated websites.
- Distributes medical alert devices through a network of wholesalers.
- Generates revenue from the sales of specialized products like MediPendant and iHelp.
- Potentially generates recurring revenue from service subscriptions associated with mobile alert systems, enabling features like remote tracking and emergency response.
What Industry Does WHSI Operate In?
Wearable Health Solutions, Inc. operates within the dynamic telehealth and remote patient monitoring industry, a sector experiencing robust growth driven by an aging global population and increasing healthcare costs. The market for personal emergency response systems (PERS), a core focus for WHSI, is projected to expand significantly as more individuals seek solutions for independent living and immediate assistance during emergencies. WHSI's offerings, such as the MediPendant and iHelp, directly address this demand by providing critical communication and location tracking capabilities. The competitive landscape is characterized by both established players and numerous startups, all vying for market share with diverse technological solutions. WHSI positions itself by specializing in dedicated medical alert devices, aiming to differentiate through features like in-pendant two-way communication and integrated dealer portals. The ongoing shift towards more sophisticated wearable biosensors, exemplified by WHSI's iHelp+3G development, reflects a broader industry trend towards proactive health and wellness monitoring, moving beyond reactive emergency services.
Who Are WHSI's Key Customers?
- Elderly individuals seeking safety, independence, and immediate assistance.
- Individuals with physical disabilities requiring reliable emergency contact systems.
- People living alone who need a quick and easy way to summon help.
- Caregivers and family members seeking peace of mind for their loved ones' safety.
How Wearable Health Solutions, Inc. Is Valued
Wearable Health Solutions, Inc. carries a market capitalization of 183K, placing it in the micro-cap category. Relative to its peer group, WHSI's quantitative score of 45/100 is below the peer average of 62/100.
Company Profile
Wearable Health Solutions, Inc. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Las Vegas, US. The company is led by CEO Peter Pizzino. WHSI has traded publicly since 2009.
ROE 84%Key Financial Metrics
Return on equity for Wearable Health Solutions, Inc. stands at 84.3%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.04 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 3/9Financial Health
Wearable Health Solutions, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
FY2026 estForward Outlook
Wall Street analysts project Wearable Health Solutions, Inc. revenue of about $1.1M for fiscal 2026, with EPS near $-0.01.
WHSI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Specialized product portfolio addressing critical needs (MediPendant, iHelp).
- Focus on a growing demographic (elderly, disabled) with increasing demand for PERS.
- Existing international presence in key markets like Denmark and China.
- Active development of next-generation biosensor technology (iHelp+3G).
Bear Case
- Very low market capitalization ($0.00B) and significant unprofitability (Profit Margin: -320.6%).
- Small operational scale with only 5 employees, limiting capacity for growth and innovation.
- Reliance on older 2G network for current iHelp system, facing potential obsolescence.
- Limited public disclosure and liquidity due to OTC Other listing.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
WHSI Latest News
No recent news available for WHSI.
WHSI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for WHSI.
Price Targets
Wall Street price target analysis for WHSI.
WHSI MoonshotScore
What does this score mean?
The MoonshotScore rates WHSI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Peter Pizzino
CEO
Peter Pizzino currently serves as the CEO of Wearable Health Solutions, Inc., leading a small team of 5 employees. Specific details regarding his prior career history, educational background, or previous executive roles are not publicly available in the provided information.
Track Record: Under Mr. Pizzino's leadership, Wearable Health Solutions, Inc. has continued the development and marketing of its core personal emergency response systems, including the MediPendant and iHelp. He has overseen the company's strategic shift towards developing advanced wearable biosensor technology with the upcoming iHelp+3G. Specific milestones or financial achievements under his direct leadership are not detailed in the provided data.
WHSI OTC Market Information
Wearable Health Solutions, Inc. trades on the OTC Other tier, which represents the lowest tier of the OTC Markets Group's three marketplaces. Unlike companies listed on major exchanges like NYSE or NASDAQ, which have stringent financial and disclosure requirements, companies on the OTC Other tier are not required to meet any minimum financial standards or file reports with the SEC. This tier typically includes companies that are very small, distressed, or have limited public information, making them highly speculative. It signifies a lack of transparency compared to higher OTC tiers (like OTCQX or OTCQB) and major exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited transparency and availability of financial information due to 'Unknown' disclosure status.
- Extremely low market capitalization and negative profit margin, indicating significant financial instability.
- High volatility and illiquidity inherent in OTC Other listed securities, making price discovery difficult.
- Lack of regulatory oversight compared to major exchanges, increasing potential for fraud or manipulation.
- Difficulty in securing institutional investment or analyst coverage due to OTC listing and small scale.
- Verify current financial statements and audit reports directly from the company or third-party sources.
- Research any pending litigation, regulatory actions, or enforcement activities against the company.
- Examine the company's business plan, product development timelines, and market strategy for viability.
- Assess the background and track record of management beyond publicly available summaries.
- Investigate the company's capital structure, outstanding shares, and potential for dilution.
- Understand the trading history and average daily volume to gauge liquidity.
- Seek independent verification of product claims and market traction.
- Active development of new products like iHelp+3G, indicating ongoing operations.
- Established product lines (MediPendant, iHelp) with specific features and target demographics.
- Identified physical headquarters in Las Vegas, US, and a stated employee count of 5.
- Existing international reach to Denmark, Ireland, Bermuda, and China.
- Clear business description focusing on a defined sector (personal emergency response systems).
What Investors Ask About Wearable Health Solutions, Inc. (WHSI) — Healthcare
What does Wearable Health Solutions, Inc. do?
Wearable Health Solutions, Inc. (WHSI) specializes in developing and marketing personal emergency response systems (PERS) and wearable health devices. The company's core offerings include the MediPendant, an emergency alarm with an in-pendant speaker for two-way communication, and iHelp, a mobile medical alert system utilizing a 2G network for remote tracking. WHSI is also actively developing iHelp+3G, a next-generation wearable biosensor for health and wellness monitoring. These solutions primarily cater to the elderly, individuals with physical disabilities, and those living alone, aiming to provide rapid assistance during emergencies and support independent living. The company distributes its products through its websites and a network of wholesalers, with an international presence in several countries.
How does Wearable Health Solutions, Inc. address the evolving technology landscape in personal emergency response systems?
Wearable Health Solutions, Inc. is actively addressing the evolving technology landscape by developing its iHelp+3G wearable biosensor device, which is designed to operate on a more advanced 3G network. This represents a strategic upgrade from its current iHelp system, which relies on the older 2G network, a technology facing eventual obsolescence. The transition to 3G for iHelp+3G aims to provide enhanced connectivity, more robust data transmission capabilities for health and wellness monitoring, and a more future-proof platform. This development indicates the company's intent to keep pace with technological advancements and expand its offerings beyond basic emergency alerts into more comprehensive remote patient monitoring solutions, aligning with broader industry trends towards integrated digital health.
What are the primary market opportunities for Wearable Health Solutions, Inc. given its focus on medical alert devices?
Wearable Health Solutions, Inc. is positioned to capitalize on several significant market opportunities. The most prominent is the rapidly expanding global aging population, which drives increasing demand for personal emergency response systems (PERS) and solutions for independent living. Furthermore, the broader telehealth and remote patient monitoring (RPM) market is experiencing substantial growth, offering WHSI a chance to expand its product utility beyond emergency response into proactive health and wellness monitoring with devices like the upcoming iHelp+3G. The company's existing international footprint in markets such as Denmark and China also presents opportunities for further global penetration, leveraging similar demographic trends and increasing healthcare technology adoption worldwide.
What are the key factors to evaluate for WHSI?
Wearable Health Solutions, Inc. (WHSI) holds an AI score of 45/100 (low). Not financial advice.
How frequently does WHSI data refresh on this page?
WHSI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven WHSI's recent stock price performance?
Wearable Health Solutions, Inc. (WHSI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized product portfolio addressing critical needs (MediPendant, iHelp). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider WHSI overvalued or undervalued right now?
Valuing Wearable Health Solutions, Inc. (WHSI) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying WHSI?
Before investing in Wearable Health Solutions, Inc. (WHSI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited to provided source data.
- Specific financial metrics beyond market cap, profit margin, gross margin, and beta were not provided.
- No specific analyst ratings or price targets were available in the source data.
- CEO background and track record details are limited to what was provided.
- Competitor information was not provided in the source data, hence an empty array.